Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities.
- DOI
- 10.1002/cac2.70005
- Published
- 2025 May
- Container
- Cancer communications (London, England)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cac2.70005,
title = {Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities.},
author = {Shan D and Song J and Ren Y and Zhang Y and Ba Y and Luo P and Cheng Q and Xu H and Weng S and Zuo A and Liu S and Han X and Deng J and Liu Z},
year = {2025},
journal = {Cancer communications (London, England)},
doi = {10.1002/cac2.70005},
url = {https://doi.org/10.1002/cac2.70005}
}RIS
TY - JOUR TI - Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities. AU - Shan D AU - Song J AU - Ren Y AU - Zhang Y AU - Ba Y AU - Luo P AU - Cheng Q AU - Xu H AU - Weng S AU - Zuo A AU - Liu S AU - Han X AU - Deng J AU - Liu Z PY - 2025 JO - Cancer communications (London, England) DO - 10.1002/cac2.70005 UR - https://doi.org/10.1002/cac2.70005 ER -
APA
D, S., J, S., Y, R., Y, Z., Y, B., P, L., Q, C., H, X., S, W., A, Z., S, L., X, H., J, D., & Z, L. (2025). Copper in cancer: friend or foe? Metabolism, dysregulation, and therapeutic opportunities.. Cancer communications (London, England). https://doi.org/10.1002/cac2.70005
Source records
- pubmed · retrieved 2026-09-26T21:18:04.368Z